Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122487963 | 12248796 | 3 | F | 201601 | 20160630 | 20160408 | 20160706 | EXP | US-PFIZER INC-2016196565 | PFIZER | 68.00 | YR | F | Y | 79.00000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122487963 | 12248796 | 1 | PS | VFEND | VORICONAZOLE | 1 | 200 MG, 2X/DAY | Y | F10253830 | 21266 | 200 | MG | FILM-COATED TABLET | BID | |||||
| 122487963 | 12248796 | 2 | SS | VFEND | VORICONAZOLE | 1 | 200 MG, 2X/DAY | Y | F10201930 | 21266 | 200 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122487963 | 12248796 | 1 | Aspergillus infection |
| 122487963 | 12248796 | 2 | Pulmonary mycosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122487963 | 12248796 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122487963 | 12248796 | Bronchitis | |
| 122487963 | 12248796 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122487963 | 12248796 | 1 | 201509 | 0 |